Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Hypertension, Interstitial Lung Disease”

92 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 92 results

Testing effectiveness (Phase 2)Looking for participantsNCT07175038
What this trial is testing

ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

Who this might be right for
Pulmonary Arterial Hypertension (PAH)Pulmonary Hypertension, Interstitial Lung Disease
AllRock Bio, Inc. 40
Not applicableStudy completedNCT02858791
What this trial is testing

MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary HypertensionPulmonary Arterial HypertensionInterstitial Lung Disease
Northwell Health 99
Large-scale testing (Phase 3)UnknownNCT00439543
What this trial is testing

Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisPulmonary Hypertension
Interstitial Lung Disease Study Group, Korea 15
Testing effectiveness (Phase 2)Study completedNCT00352482
What this trial is testing

Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension

Who this might be right for
Pulmonary FibrosisHypertension, Pulmonary
National Heart, Lung, and Blood Institute (NHLBI) 20
Large-scale testing (Phase 3)Ended earlyNCT03267108
What this trial is testing

Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension

Who this might be right for
Pulmonary FibrosisPulmonary Hypertension
Bellerophon Pulse Technologies 145
Not applicableStudy completedNCT05703802
What this trial is testing

Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia.

Who this might be right for
SepsisPre-EclampsiaGranulomatosis With Polyangiitis+4 more
University Hospital Muenster 30
Early research (Phase 1)Study completedNCT05427253
What this trial is testing

First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects

Who this might be right for
Safety IssuesToleranceIdiopathic Pulmonary Fibrosis+1 more
Vicore Pharma AB 80
Not applicableStudy completedNCT01615484
What this trial is testing

Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability

Who this might be right for
EmphysemaChronic Obstructive Pulmonary Disease (COPD)Cystic Fibrosis+5 more
University of North Carolina, Chapel Hill 24
Not applicableUnknownNCT04650659
What this trial is testing

Functional Exercise Tests in Patients With Systemic Sclerosis

Who this might be right for
Scleroderma, SystemicLung Diseases, InterstitialPulmonary Arterial Hypertension+1 more
University of Aarhus 83
Not applicableStudy completedNCT00926523
What this trial is testing

Biomarkers in the Evaluation of Chronic Lung Disease

Who this might be right for
Pulmonary HypertensionPulmonary Arterial HypertensionInterstitial Lung Disease
Northwell Health 67
Large-scale testing (Phase 3)Not Yet RecruitingNCT07285655
What this trial is testing

Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

Who this might be right for
Pulmonary Hypertension Due to Lung Disease (Disorder)
Liquidia Technologies, Inc. 344
Testing effectiveness (Phase 2)Looking for participantsNCT06635850
What this trial is testing

Mosliciguat in PH-ILD

Who this might be right for
Pulmonary HypertensionInterstitial Lung DiseaseLung Diseases+3 more
Pulmovant, Inc. 120
Not applicableAvailableNCT05572996
What this trial is testing

Inhaled Treprostinil Expanded Access Program in Pulmonary Hypertension Associated With Interstitial Lung Disease

Who this might be right for
Pulmonary HypertensionInterstitial Lung DiseaseCombined Pulmonary Fibrosis and Emphysema
Ferrer Internacional S.A.
Not applicableUnknownNCT05662995
What this trial is testing

Point-of-care Ultrasound Abnormalities in Early Onset Preeclampsia

Who this might be right for
PreeclampsiaPulmonary EdemaCardiac Function
University of Cape Town 60
Not applicableNot Yet RecruitingNCT06416163
What this trial is testing

FIBRotic Interstitial Lung Disease With Nocturnal hypOXaemia and EXercise Induced desaTuRAtion

Who this might be right for
Interstitial Lung DiseaseFibrosis LungPulmonary Hypertension
Guy's and St Thomas' NHS Foundation Trust 160
Large-scale testing (Phase 3)Study completedNCT00517933
What this trial is testing

Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisHypertension, Pulmonary
Duke University 180
Testing effectiveness (Phase 2)Study completedNCT03814317
What this trial is testing

Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension

Who this might be right for
SarcoidosisPrecapillary Pulmonary HypertensionInterstitial Lung Disease
University of Florida 5
Testing effectiveness (Phase 2)Study completedNCT05564637
What this trial is testing

Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension

Who this might be right for
Pulmonary Arterial HypertensionInterstitial Lung DiseaseHealthy Adults
Mayo Clinic 29
Not applicableEnded earlyNCT01241942
What this trial is testing

Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability

Who this might be right for
EmphysemaChronic Obstructive Pulmonary Disease (COPD)Cystic Fibrosis+5 more
University of North Carolina, Chapel Hill 11
Not applicableAvailableNCT06939647
What this trial is testing

An Expanded Access Study to Assess Treprostinil Palmitil Inhalation Powder (TPIP) for Participants With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension, Interstitial Lung Disease
Insmed Incorporated
Load More Results